Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-048612

Chief Financial Officer bought 9,490 shares at $7.90 ($74,971)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Balthaser Kevin Chief Financial Officer 2023-09-06 Purchase +9,490 $7.90 $74,971 15,461 D
Open-market purchases · 9,490 sh · avg $7.90 · $74,971
Loading xslF345X05/doc4.xml…